LA Times, Baltimore Sun, others: More reliable prostate cancer test on the way?
Thursday, April 26th, 2007
The first trial of a new blood test is promising more reliable diagnoses for prostate cancer. Not only does the current PSA test fail to detect some cancers, its high level of “false positives” causes more than a million men a year to unnecessarily endure the pain of biopsies. Jonathan Bor in the Baltimore Sun and Susan Brink in the Los Angeles Times, among others, report on findings of a study published in the journal Urology. Conducted by Robert H. Getzenberg, of Johns Hopkins University, the test of 385 men was sponsored by Onconome Inc., a privately-held Seattle biotech company that developed the test that relies on measure levels of a blood protein called EPCA-2. More and bigger trials remain to be completed, but Getzenberg said the new test could become available sometime as early as 2008. Anne Underwood in Newsweek has in interview of Getzengerg.
Grist for the Mill: Onconome, Inc., press release
-JDC